Talking out of your A$$ again.
Chine with their review vision of brining innovation to the Pharma industry changed their system and processes regarding IP especially of Pharma brands more than 15 years ago.
In addition to that, China invested heavily in their Pharmaceutical sector where today most drugs have very healthy govt subsidies that is dependent on your status, province etc.
That change resulted in MNC's investing heavily in China over the last decade not only into selling drugs but also their R&D investment.
The market is massive and only going to get bigger. No wonder every Pharma company has winning in China as their next focus after Us market.
You are a clown who has absolutely no idea how things works which is obvious from your posts anyway.
The only thing when it comes to Pharma where India and China is aligned is Population.
Talking out of your A$$ again. Chine with their review vision of...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.025(7.46%) |
Mkt cap ! $197.8M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.3¢ | 33.5¢ | $3.801M | 10.73M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 378856 | 6 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
36.0¢ |
Change
0.025 ( 7.33 %) |
||||
| Open | High | Low | Volume | ||
| 33.5¢ | 36.5¢ | 33.5¢ | 5557634 | ||
| Last updated 15.58pm 03/05/2024 ? | |||||
| DXB (ASX) Chart |